FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885409162> ?p ?o ?g. }

• W2885409162 endingPage "8859" @default.
• W2885409162 startingPage "8847" @default.
• W2885409162 abstract "We investigated the effects of monensin controlled-release capsule (CRC; Kexxtone, Eli Lilly and Company Ltd., Indianapolis, IN) preventative ketosis treatment on the traditional cheesemaking process as well as the final characteristics of Parmigiano Reggiano (PR) cheese. The use of this prevention product to reduce the incidence of ketosis in transition dairy cows was approved by the European Medicines Agency in 2013. No previous studies are available concerning the effects of this treatment on prolonged-ripening cheese production such as PR. In PR cheese production, feed, feed additives, and cow treatments are strictly regulated to avoid any possible interference with traditional manufacturing processes. For these reasons, on 1 farm where all milk was used for PR cheese production, monensin CRC was administered to 33 cows, 21 d before calving in the monensin-treated group (TRT), whereas untreated cows with similar breed and parity characteristics constituted the control group (CTR). For 20 wk, milk obtained from each group and whey starter were separately managed and transported in the cheese factory, where 2 cheese wheels per group were produced daily, making 552 PR cheese wheels in total. Morning bulk tank milk composition, cheesemaking properties, and whey starter fermentation activities were analyzed twice a week. Every aspect of the cheesemaking process was recorded and the resulting cheese was evaluated after 36 h and 6, 12, and 18 mo from production for yield, texture defects, composition, and fatty acids profile. Milk from the 2 groups differed for somatic cell content (TRT = 3.04 vs. CTR = 4.06, somatic cell score), total bacterial count (TRT = 4.08 vs. CTR = 6.08 × 1,000 cfu/mL), titratable acidity (TRT = 3.66 vs. CTR = 3.72 Soxhlet-Henkel degrees/50 mL), and casein content percentage (TRT = 2.4 vs. CTR = 2.5%). Whey starter parameters were comparable between the 2 groups. Final cheese composition and organoleptic profile were not influenced by the treatment, except for C18:1 content being enhanced (TRT = 22.8 vs. CTR = 20.8% of fatty acids). Percentage of defected ripened cheese was significantly lower in the treated group, both at x-ray evaluation performed at 6 mo (TRT = 6.2 vs. CTR = 12.3%) and at the consortium inspection, performed at 12 mo of ripening (TRT = 1.5 vs. CTR = 6.5%). On the other hand, average cheese yield at 18 mo of ripening was partially reduced (TRT = 7.5 vs. CTR = 7.7%). Overall, the use of monensin CRC had no negative effect on the cheesemaking process, prolonged ripening cheese characteristics, milk composition, or whey starter quality." @default.
• W2885409162 created "2018-08-22" @default.
• W2885409162 creator A5000543406 @default.
• W2885409162 creator A5004303937 @default.
• W2885409162 creator A5012592263 @default.
• W2885409162 creator A5019229758 @default.
• W2885409162 creator A5048726492 @default.
• W2885409162 creator A5049873781 @default.
• W2885409162 creator A5069473938 @default.
• W2885409162 creator A5073625025 @default.
• W2885409162 date "2018-10-01" @default.
• W2885409162 modified "2023-09-26" @default.
• W2885409162 title "Does the dry cow treatment with monensin controlled release capsule affect Parmigiano Reggiano cheese production?" @default.
• W2885409162 cites W1155988424 @default.
• W2885409162 cites W118591756 @default.
• W2885409162 cites W1576277607 @default.
• W2885409162 cites W1874781100 @default.
• W2885409162 cites W1963733922 @default.
• W2885409162 cites W1970440644 @default.
• W2885409162 cites W1972529226 @default.
• W2885409162 cites W1972916516 @default.
• W2885409162 cites W1973727507 @default.
• W2885409162 cites W1986088383 @default.
• W2885409162 cites W1989898497 @default.
• W2885409162 cites W2007356554 @default.
• W2885409162 cites W2008076410 @default.
• W2885409162 cites W2009435891 @default.
• W2885409162 cites W2018006433 @default.
• W2885409162 cites W2032434235 @default.
• W2885409162 cites W2045581902 @default.
• W2885409162 cites W2055816649 @default.
• W2885409162 cites W2059065711 @default.
• W2885409162 cites W2061072477 @default.
• W2885409162 cites W2061220316 @default.
• W2885409162 cites W2064424653 @default.
• W2885409162 cites W2072370509 @default.
• W2885409162 cites W2074686769 @default.
• W2885409162 cites W2075251005 @default.
• W2885409162 cites W2077090405 @default.
• W2885409162 cites W2092387702 @default.
• W2885409162 cites W2094055707 @default.
• W2885409162 cites W2099751340 @default.
• W2885409162 cites W2100742790 @default.
• W2885409162 cites W2104078534 @default.
• W2885409162 cites W2133822268 @default.
• W2885409162 cites W2133865157 @default.
• W2885409162 cites W2139027934 @default.
• W2885409162 cites W2144748715 @default.
• W2885409162 cites W2147697290 @default.
• W2885409162 cites W2153465869 @default.
• W2885409162 cites W2153800013 @default.
• W2885409162 cites W2163638131 @default.
• W2885409162 cites W2168526937 @default.
• W2885409162 cites W2178410878 @default.
• W2885409162 cites W2282426240 @default.
• W2885409162 cites W2597517880 @default.
• W2885409162 cites W2758023301 @default.
• W2885409162 cites W2787810248 @default.
• W2885409162 doi "https://doi.org/10.3168/jds.2017-14299" @default.
• W2885409162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30100500" @default.
• W2885409162 hasPublicationYear "2018" @default.
• W2885409162 type Work @default.
• W2885409162 sameAs 2885409162 @default.
• W2885409162 citedByCount "6" @default.
• W2885409162 countsByYear W28854091622020 @default.
• W2885409162 countsByYear W28854091622021 @default.
• W2885409162 countsByYear W28854091622023 @default.
• W2885409162 crossrefType "journal-article" @default.
• W2885409162 hasAuthorship W2885409162A5000543406 @default.
• W2885409162 hasAuthorship W2885409162A5004303937 @default.
• W2885409162 hasAuthorship W2885409162A5012592263 @default.
• W2885409162 hasAuthorship W2885409162A5019229758 @default.
• W2885409162 hasAuthorship W2885409162A5048726492 @default.
• W2885409162 hasAuthorship W2885409162A5049873781 @default.
• W2885409162 hasAuthorship W2885409162A5069473938 @default.
• W2885409162 hasAuthorship W2885409162A5073625025 @default.
• W2885409162 hasBestOaLocation W28854091621 @default.
• W2885409162 hasConcept C100544194 @default.
• W2885409162 hasConcept C140793950 @default.
• W2885409162 hasConcept C150903083 @default.
• W2885409162 hasConcept C185592680 @default.
• W2885409162 hasConcept C22641795 @default.
• W2885409162 hasConcept C2776477769 @default.
• W2885409162 hasConcept C2776544680 @default.
• W2885409162 hasConcept C2776659692 @default.
• W2885409162 hasConcept C2776792119 @default.
• W2885409162 hasConcept C2777176278 @default.
• W2885409162 hasConcept C2778724459 @default.
• W2885409162 hasConcept C2779234561 @default.
• W2885409162 hasConcept C2780224938 @default.
• W2885409162 hasConcept C31903555 @default.
• W2885409162 hasConcept C54355233 @default.
• W2885409162 hasConcept C86803240 @default.
• W2885409162 hasConceptScore W2885409162C100544194 @default.
• W2885409162 hasConceptScore W2885409162C140793950 @default.
• W2885409162 hasConceptScore W2885409162C150903083 @default.
• W2885409162 hasConceptScore W2885409162C185592680 @default.
• W2885409162 hasConceptScore W2885409162C22641795 @default.

• next